Provincia Lombardo Veneta Dell’ordine Ospedaliero Di San Giovanni Di Dio Fatebenefratelli
- Address
- lock Available on a paid plan
Nervous System Diseases and Alzheimer’s Research
At Provincia Lombardo Veneta Dell’ordine Ospedaliero Di San Giovanni Di Dio Fatebenefratelli in Brescia, most studies focus on Alzheimer’s disease and related neurodegenerative diseases. The research is aimed at finding new ways to slow cognitive decline, protect brain function, and improve overall disease management.
- Testing new therapies for mild to moderate Alzheimer’s disease dementia
- Evaluating treatments intended to preserve memory and thinking skills
- Studying long-term safety and tolerability of investigational approaches
- Exploring biomarkers linked to disease progression and treatment response
This work reflects a strong clinical interest in both treatment effectiveness and early intervention for people living with or at risk for Alzheimer’s disease.
Psychiatry and Psychology in Alzheimer’s-Related Mental Disorders
The site also investigates mental disorders linked to dementia, especially psychosis associated with Alzheimer’s disease and agitation. These trials are designed to improve behavioral symptoms that can greatly affect quality of life for patients and caregivers.
- Assessing treatments for psychosis in Alzheimer’s disease
- Studying options to reduce hallucinations and delusions
- Evaluating therapies for agitation in Alzheimer’s disease dementia
- Measuring how well symptom control can be maintained over time
This area combines psychiatric care with dementia research to address some of the most challenging symptoms seen in advanced Alzheimer’s disease.
Genetic Alzheimer’s Disease and Prevention Research
Another important line of research at this hospital/clinic involves Dominantly Inherited Alzheimer Disease and other inherited forms of early-onset dementia. The studies aim to learn whether treatment can delay or prevent disease onset in people carrying disease-causing mutations.
- Studying prevention strategies for people at genetic risk for Alzheimer’s disease
- Tracking changes in brain-related biomarkers linked to early disease activity
- Evaluating whether investigational treatments can slow progression before symptoms worsen
- Supporting research in families affected by inherited neurodegenerative disease
This research is especially valuable for understanding how Alzheimer’s disease develops and how it might be delayed before major cognitive decline begins.
Depression and Inflammation-Related Mental Health Research
The site includes work in psychiatry beyond dementia, with a study focused on depression and the role of inflammation in treatment response. The goal is to better understand whether adding a new therapy can improve symptoms and biological markers in patients already receiving standard care.
- Investigating treatment effects in depressed patients
- Exploring links between mood symptoms and peripheral inflammatory status
- Assessing whether symptoms improve alongside biological changes
- Supporting broader research into personalized approaches for mental disorders
This adds an important non-dementia dimension to the research portfolio, connecting psychiatry with biological markers of disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Provincia Lombardo Veneta Dell’ordine Ospedaliero Di San Giovanni Di Dio Fatebenefratelli
lock Showing 1 of 12 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Continuation Study of Latozinemab in Patients with Neurodegenerative Diseases Following Prior Participation in Alector-Sponsored Trials | Alector LLC | Phase III | Not Recruiting | Sep 2024 | Jan 2026 |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Trospium Chloride | 3 | Unknown | 2024-05-09 | 2025-08-25 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.